Related Experiment Video
Updated: Apr 23, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Patient selection for TAVI in 2014: is there a justification for treating low- or intermediate-risk patients? The
Arie Pieter Kappetein1, Ruben L J Osnabrugge, Stuart J Head
1Department of Thoracic Surgery, Erasmus MC, Rotterdam, The Netherlands.
Abstract:
The introduction of transcatheter aortic valve implantation (TAVI) has revolutionised the treatment of patients with symptomatic severe aortic valve stenosis (AS). In extreme and high-risk patients, randomised studies have shown the benefit of this new therapy. However, there are still a lot of unknowns, and the question has arisen whether it is justified to expand the indication of TAVI to other patient groups, especially intermediate-or even low-risk patients.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse II: Assessment and Management

